The global lung cancer market is touted to reach USD 20.05 Billion by the end of 2024 which was valued at USD 40.60 Billion in 2032 and expand at a progressive CAGR of 8.15% over the forecast period of 2024-2032, proclaims Market Research Future (MRFR) in an exhaustive study. High prevalence of lung cancer is the primary reason behind the growth of the market which results in higher screening,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian